Frontiers | Selective IgM Deficiency—An Underestimated Primary Immunodeficiency
Immunoglobulin testing – RefHelp
Systems serology detects functionally distinct coronavirus antibody features in children and elderly | Nature Communications
Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii) | Scientific Reports
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition | Nature Communications
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals - ScienceDirect
RACGP - Multiple myeloma: from diagnosis to treatment
B cell extracellular vesicles contain monomeric IgM that binds antigen and enters target cells - ScienceDirect
Biology | Free Full-Text | Modeling Dengue Immune Responses Mediated by Antibodies: A Qualitative Study
Frontiers | Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients
Hepatitis A (hep A) - exclusion from work and school advice – GPNotebook
GPnotebook
Frontiers | Serum Immunoglobulins, Pneumonia Risk, and Lung Function in Middle-Aged and Older Individuals: A Population-Based Cohort Study
The Hyper IgM Syndrome—An Evolving Story | Pediatric Research
Frontiers | Selective IgM Deficiency—An Underestimated Primary Immunodeficiency
Frontiers | Evaluation of Patient IgM and IgG Reactivity Against Multiple Antigens for Improvement of Serodiagnostic Testing for Early Lyme Disease
Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design - ScienceDirect
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition | Nature Communications
Diagnostics | Free Full-Text | Kawasaki Disease and Inborn Errors of Immunity: Exploring the Link and Implications
Primary care education – Myeloma Academy
MGUS — HaemBase
An overview of blood disorders in the elderly. - Document - Gale Academic OneFile
GP Myeloma Diagnostic Tool – Myeloma Academy
